Cargando…

The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability

There is a high prevalence of cannabis use reported in non-affective psychosis. Early prospective longitudinal studies conclude that cannabis use is a risk factor for psychosis, and neurochemical studies on cannabis have suggested potential mechanisms for this effect. Recent advances in the field of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Løberg, Else-Marie, Helle, Siri, Nygård, Merethe, Berle, Jan Øystein, Kroken, Rune A., Johnsen, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235385/ https://www.ncbi.nlm.nih.gov/pubmed/25477825 http://dx.doi.org/10.3389/fpsyt.2014.00159

Ejemplares similares

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2012)

Corrigendum: An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2013)

Patients with Schizophrenia Fail to Up-Regulate Task-Positive and Down-Regulate Task-Negative Brain Networks: An fMRI Study Using an ICA Analysis Approach
por: Nygård, Merethe, et al.
Publicado: (2012)

A Critical Review of Pro-Cognitive Drug Targets in Psychosis: Convergence on Myelination and Inflammation
por: Kroken, Rune A., et al.
Publicado: (2014)

Corrigendum: Patients with schizophrenia fail to up-regulate task-positive and down-regulate task-negative brain networks: an fMRI study using an ICA analysis approach
por: Nygård, Merethe, et al.
Publicado: (2013)

Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms
por: Anda, Liss, et al.
Publicado: (2019)

Dynamic Functional Connectivity Patterns in Schizophrenia and the Relationship With Hallucinations
por: Weber, Sarah, et al.
Publicado: (2020)

Cannabis and psychosis: Neurobiology
por: Shrivastava, Amresh, et al.
Publicado: (2014)

Neurobiology of Cognitive Remediation Therapy for Schizophrenia: A Systematic Review
por: Thorsen, Anders Lillevik, et al.
Publicado: (2014)

The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement
por: Anda, Liss, et al.
Publicado: (2016)

Glutamate- and GABA-Modulated Connectivity in Auditory Hallucinations—A Combined Resting State fMRI and MR Spectroscopy Study
por: Weber, Sarah, et al.
Publicado: (2021)

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
por: Johnsen, Erik, et al.
Publicado: (2013)

S57. TREATMENT SATISFACTION IN ACUTE PHASE PSYCHOSIS: COMPARISON BETWEEN ANTIPSYCHOTIC NAïVE AND PREVIOUSLY MEDICATED PATIENTS
por: Stabell, Lena, et al.
Publicado: (2018)

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
por: Johnsen, Erik, et al.
Publicado: (2013)

The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
por: Johnsen, Erik, et al.
Publicado: (2016)

S87. THE INITIAL CHANGE IN THE SERUM LEVEL OF C-REACTIVE PROTEIN IN ACUTE PSYCHOSIS IS ASSOCIATED WITH COGNITIVE PERFORMANCE IN LATER PHASES
por: Fathian, Farivar, et al.
Publicado: (2018)

Editorial: Neurobiology and Cognition Across the Autism-Psychosis Spectrum
por: Sasson, Noah J., et al.
Publicado: (2021)

Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences
por: Navarrete, Francisco, et al.
Publicado: (2020)

Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis
por: Fathian, Farivar, et al.
Publicado: (2018)

Neurobiological mechanisms of psychosis in epilepsy: Findings from neuroimaging studies
por: Sone, Daichi
Publicado: (2022)

Left Temporal Lobe Structural and Functional Abnormality Underlying Auditory Hallucinations in Schizophrenia
por: Hugdahl, Kenneth, et al.
Publicado: (2009)

Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
por: Bramness, Jørgen G, et al.
Publicado: (2012)

Pathways from Cannabis to Psychosis: A Review of the Evidence
por: Burns, Jonathan K.
Publicado: (2013)

Minimizing policy-biased appraisals of the evidence on cannabis and psychosis
por: Hall, Wayne
Publicado: (2023)

Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study
por: Johnsen, Erik, et al.
Publicado: (2011)

Sex-Dependent Vulnerability to Cannabis Abuse in Adolescence
por: Rubino, Tiziana, et al.
Publicado: (2015)

Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological Targets
por: Schultze-Lutter, Frauke, et al.
Publicado: (2016)

Gone to Pot – A Review of the Association between Cannabis and Psychosis
por: Radhakrishnan, Rajiv, et al.
Publicado: (2014)

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
por: Kjelby, Eirik, et al.
Publicado: (2011)

Down and High: Reflections Regarding Depression and Cannabis
por: Langlois, Catherine, et al.
Publicado: (2021)

Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
por: Kroken, Rune A., et al.
Publicado: (2019)

Computational Mechanism for the Effect of Psychosis Community Treatment: A Conceptual Review From Neurobiology to Social Interaction
por: Benrimoh, David, et al.
Publicado: (2021)

Editorial: Clinical High Risk for Psychosis: From Epidemiological Findings to Neurobiological Underpinnings of Treatment Response and Outcome
por: Michel, Chantal, et al.
Publicado: (2021)

Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT
por: Anda, Liss, et al.
Publicado: (2021)

Identifying Four Subgroups of Trauma in Psychosis: Vulnerability, Psychopathology, and Treatment
por: Stevens, Lucy H., et al.
Publicado: (2017)

Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
por: Oliver, Dominic, et al.
Publicado: (2023)

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

A brain imaging study of dopamine receptor D(2) availability in cannabis dependent users after recovery from cannabis-induced psychosis
por: Weinstein, Aviv M.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_shp5acpjugulvr7bt50nh3idrg